Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Other Operating Expenses (2023 - 2025)

Historic Other Operating Expenses for Zentalis Pharmaceuticals (ZNTL) over the last 3 years, with Q1 2025 value amounting to -$4000.0.

  • Zentalis Pharmaceuticals' Other Operating Expenses changed N/A to -$4000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year change of. This contributed to the annual value of $3.7 million for FY2024, which is 9180.13% down from last year.
  • Per Zentalis Pharmaceuticals' latest filing, its Other Operating Expenses stood at -$4000.0 for Q1 2025.
  • Zentalis Pharmaceuticals' 5-year Other Operating Expenses high stood at $45.6 million for Q2 2023, and its period low was -$4000.0 during Q1 2025.
  • Its 3-year average for Other Operating Expenses is $16.4 million, with a median of $3.7 million in 2024.